USPTO 2015–2025 USPTO PatentsView US Corporation

Katalyst Surgical, Llc

USPTO PatentsView assignee record - 130 granted patents across 10 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

130

Total patents granted

CPC technology areas

18.6

Avg claims per patent

-88%

5-year filing velocity

The verdict

Katalyst holds 130 US patents across 10 technology areas, rank #2,932 of 50,000 tracked assignees.

#2,932
of 50,000 US assignees by volume: Top 38%
by Innovation Score (39.4/100): 18.6
avg claims per patent: -88%
filing velocity, last 5 yrs

Portfolio overview

Katalyst Surgical, Llc has been granted 130 US utility patents between 2015 and 2024, placing Katalyst Surgical, Llc at rank #2,932 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Katalyst Surgical, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Katalyst sits between Dalian Institute OF Chemical Physics, Chinese Academy OF Sciences (130 patents, rank #2,928) and Shanghai United Imaging Intelligence Co., Ltd. (130 patents, rank #2,936) - the closest US assignees by grant volume. The composite Innovation Score of 39.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 14 grants, compared with 116 in the 2015–2019 window, a -88% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Katalyst Surgical, Llc's 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Katalyst Surgical, Llc against peers pursuing similar technology classes.

Dalian Institute…

130
Glaxo Group

130
Husky Injection M…

130
Kansas State Univ…

130
MTU Friedrichshaf…

130
Munchkin

130
Self

130
Shanghai United I…

130
Katalyst Surgical ◀

130

What this shows Katalyst holds 130 patents at rank #2,932, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Katalyst

By rank, the assignees closest to #2,932 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Katalyst's primary technology class.

Katalyst's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Katalyst Surgical, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	17	13.1%
2016	31	23.8%
2017	33	25.4%
2018	22	16.9%
2019	13	10.0%
2020	11	8.5%
2021	2	1.5%
2024	1	0.8%

Which technologies does Katalyst Surgical, Llc patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 122

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 120

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 19

B33Y - ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING 6

B23K - SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM 4

A63C - SKATES; SKIS; ROLLER SKATES; DESIGN OR LAYOUT OF COURTS, RINKS OR THE LIKE 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 2

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 1

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 1

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#2,932

Across all tracked assignees

Innovation Score

39.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Katalyst Surgical, Llc hold?

Katalyst Surgical, Llc holds 130 US granted patents filed between 2015 and 2024, spanning 10 technology areas.

What is Katalyst Surgical, Llc's Innovation Score?

Katalyst Surgical, Llc has an Innovation Score of 39.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Katalyst Surgical, Llc focus on?

Katalyst Surgical, Llc's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 122 patents. The company has filed patents in 10 CPC subclasses total.

Is Katalyst Surgical, Llc's patent filing rate increasing or decreasing?

Katalyst Surgical, Llc's recent filing velocity is -88% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Katalyst Surgical, Llc's patents?

Katalyst Surgical, Llc's patents average 18.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Katalyst Surgical, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Katalyst's 130 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Katalyst ranks #2,932 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.